Association between the risk of obstructive sleep apnea and neurological diseases in the neurology outpatient clinic of the Alcides Carneiro University Hospital.
Abstract
Background: Obstructive Sleep Apnea (OSA) is a highly prevalent and underdiagnosed disorder associated with several systemic conditions. Emerging evidence suggests that OSA may act as a modifiable factor in neurological disorders, particularly those involving cognitive impairment. Therefore, investigating its presence among neurological patients becomes relevant for the diagnosis and management of these conditions. Objective: To assess the prevalence of high risk for OSA among patients attending the Neurology outpatient clinic and explore possible associations with clinical aspects. Methods: A cross-sectional, analytical, and observational study with a preliminary sample of 10 patients (N=10) at the Neurology outpatient clinic of the Alcides Carneiro University Hospital. The risk of OSA was stratified using the STOP-Bang questionnaire (high risk: 5-8 points; low risk: 0-4). Cognitive function was measured using the Mini-Mental State Examination (MMSE) and pain intensity using the Visual Analog Scale (VAS). Data analysis was performed using descriptive statistics and nonparametric tests (Fisher's and Mann-Whitney tests) due to sample restrictions and non-normal distribution confirmed by the Shapiro-Wilk test. Results: The average age of the sample was 59.6 years (±18.75), with 50% classified as high risk for OSA. Systemic arterial hypertension (SAH) was present in 60% of the sample. The mean MMSE score was 21.0 points (±5.51), while the mean VAS score was 8.67 (±1.03). Comparative analysis using the Mann–Whitney U test revealed no statistically significant differences between the high- and low-risk OSA groups regarding cognitive performance (p = 1.000) or pain intensity (p = 1.000). Fisher's exact test demonstrated a statistically significant association between the presence of snoring and the high-risk group for OSA (p = 0.048). However, no significant associations were observed between high risk for OSA and SAH (p=0.524), sex (p=0.527), or headache (p=1.000). Conclusion: Although no statistically significant associations were found between OSA risk and the evaluated outcomes, these findings should be interpreted cautiously due to the limited sample size. The results highlight the importance of larger studies to better assess the potential relationship between OSA risk and cognitive impairment in neurological patients. Further investigation of this potentially modifiable risk factor may support the development of therapeutic strategies aimed at early intervention and improved disease outcomes.